Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.30
Bid: 7.20
Ask: 7.40
Change: -0.10 (-1.35%)
Spread: 0.20 (2.778%)
Open: 7.30
High: 7.40
Low: 7.30
Prev. Close: 7.40
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Rebellyous Foods

15 Oct 2019 07:00

RNS Number : 8137P
Agronomics Limited
15 October 2019
 

7.00am 15 October 2019

 

Agronomics Limited

 

("Agronomics" or the "Company")

 

Investment in Seattle Food Tech, Inc. trading as Rebellyous Foods

 

The Board of Agronomics Limited is pleased to announce an investment in the plant-based alternative protein company Seattle Food Tech, Inc. trading as Rebellyous Foods ("Rebellyous"). The investment is USD $250,000.00 (the "Subscription") in the form of a Simple Agreement for Future Equity (the "SAFE"), that will convert to approximately 1% equity in the next priced funding round. Rebellyous is an early stage, pre-revenue food technology and manufacturing company focused on developing plant-based chicken nuggets at scale to be price competitive with conventional chicken nuggets. Based in Seattle USA, their cash burn rate is approximately US$ 83,000 per month. The Subscription will be paid using cash from the Company's own resources.

 

This is Agronomics' first investment in the plant-based space, to complement its existing portfolio of cultivated meat and pet food companies. The team at Agronomics believe this investment supports the need for sustainable food alternatives to existing meat products.

 

Richard Reed, Chairman of Agronomics, commented on the investment: -

 

"We are very excited to secure our first plant-based opportunity in the sector - Rebellyous Foods. Rebellyous is a very interesting company, whose founder, Christie Lagally, has extensive expertise in engineering and manufacturing design that will facilitate scale-up. We see this as an opportunity for plant-based products to be price competitive with real meat in the future. Agronomics look forward to seeing Rebellyous's progress over the next few years as the plant-based trend continues."

 

Christie Lagally, Founder and CEO of Rebellyous commented: -

"We are thrilled to partner with Agronomics in our work to transform a global industry. At Rebellyous, we are building a more efficient, profitable, and sustainable meat industry by reimagining the way meat is made. Through our novel production technology, we are enabling the production of plant-based meat at a scale not previously seen in this sector, and we could not do it without support from Agronomics."

Terms of the SAFE

 

A SAFE is a "Simple Agreement for Future Equity". SAFE Agreements have similar characteristics to Convertible Loans and are designed to provide an early investor with an "edge" ahead of a larger planned funding. The edge is typically conversion of funds advanced for new equity at a discount to the subsequent raise. They are popular as it prevents a relatively small early investor setting a price for a round (which is set later by a lead investor), reducing the need for extensive due diligence and extensive negotiations regarding valuation. SAFE Agreements are increasingly popular in the US (they remain relatively rare in Europe) and are commonly used by tech and life science companies where the early stage of the IP is difficult to value. Being a SAFE investor also means an investor is not a creditor in a future insolvency.

 

The SAFE Agreement

If the funding price of new shares issued by Rebellyous in an Equity Fundraising is less than US$17 million (the "Valuation Cap") then the funds advanced by the Company will be converted at the issue price per share of the fundraise, or if the same or greater than the Valuation Cap, they will be issued at a price per share equivalent to the Valuation Cap. It would be typical for funds advanced under a SAFE to be converted at a discount to the issue price, although this is not the case here.

 

In the event of a Liquidity Event (change of control) the funds advanced under the SAFE are (at the election of the investor) repaid or immediately prior to the Liquidity Event converted at the Liquidity Price (Valuation Cap / issued shares).

 

Following a Dissolution Event to the extent there are funds available to be distributed they are paid first to SAFE investors (pro rata).

 

Following conversion, the Company is required to sign relevant transaction documents (shareholders' agreement, investor rights agreement etc. At this stage (ahead of the planned funding round) the terms of those documents (for example, in relation to drag and tag, board representation, rights of pre-emption, lock-up etc.), and the rights of the shares issued on conversion (voting rights, liquidation or distribution preference etc.) are unknown. The terms of the new equity will be negotiated (typically) by the lead investor at such time.

 

The SAFE terminates when the funds are converted to shares, or following repayment.

 

About Rebellyous

 

Rebellyous, a leader in plant-based meat production innovation, creates delicious, cost-competitive plant-based meat for the foodservice industry. Driven by engineers, food scientists, and chefs, Rebellyous uses quality plant protein, high-throughput manufacturing automation, innovative low-energy manufacturing tools, and uniquely designed modular production facilities to craft better tasting, more affordable plant-based meat.

 

About Agronomics

 

Agronomics is an investment company focused on opportunities within the nascent industry of modern foods, which are environmentally friendly alternatives to the traditional production of meat and plant-based sources of nutrition. It established an investment policy in April 2019, with a board of directors including Richard Reed, Jim Mellon, David Giampaolo, Denham Eke and Anderson Whamond. The Agronomics team are highly experienced entrepreneurs, investors and advisors with a track record of success.

Agronomics believes that the recent developments within cellular agriculture and alternative protein space will provide valuable contributions to meet the demands of increased global population growth and meat consumption in the future. The company sees cellular agriculture and aquaculture (also called cultivated meat or "clean meat") as a viable solution to relieve the pressure on arable farming and land usage.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR'). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain. 

For further information, please contact:

Agronomics Limited

Beaumont Cornish Limited

Optiva Securities Limited

Peterhouse Capital Limited

Britton Financial PR

The Company

Nomad

Joint Broker

Joint Broker

Investor Relations

enham Eke

+44 (0) 1624 639396

Roland Cornish/James Biddle

+44 (0) 207 628 3396

Jeremy King

+44 (0) 203 137 1904

Lucy Williams

+44 (0) 207 469 0936

 

Tim Blackstone

+44 (0)7957 1404

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGGGQAUUPBGPC
Date   Source Headline
16th Dec 20207:00 amRNSInvestment in SuperMeat
14th Dec 20207:00 amRNSFinal Results
9th Dec 20207:00 amRNSInvestment in CellX
7th Dec 20201:00 pmRNSPortfolio Update: Mosa Meat
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSPortfolio Update: Solar Foods receives EUR4.3m
19th Nov 20207:00 amRNSAnnounces Investment of US$ 5 million in BlueNalu
11th Nov 20202:59 pmRNSAgronomics November Newsletter 2020
10th Nov 20209:46 amRNSClosure of Broker Option & TVR
2nd Nov 20207:00 amRNSHolding(s) in Company
26th Oct 20207:00 amRNSEquity Fundraise of £10.0 million
15th Oct 20207:30 amRNSInvestee Company Update: LIVEKINDLY Collective
15th Oct 20207:00 amRNSNet Asset Value(s)
29th Sep 20202:54 pmRNSPortfolio Company Shiok Meats completes Financing
29th Sep 20207:00 amRNSAppointment of Joint Broker
25th Sep 20207:00 amRNSAnnounces Participation in Mosa Meat Financing
1st Sep 20201:00 pmRNSInvestment in Solar Foods EUR 15million Financing
12th Aug 20207:00 amRNSDirectorate Change
20th Jul 20207:00 amRNSNet Asset Value - 30 June 2020
1st Jul 202012:00 pmRNSConclusion of consultation being to remain on AIM
19th Jun 20207:00 amRNSConsultation on Possible De-Listing & Tender Offer
15th Jun 202012:10 pmRNSHolding(s) in Company
11th Jun 20207:00 amRNSCo-lead of Meatable B.V.’s Seed 2 Financing
14th Apr 20207:00 amRNSNet Asset Value calculation to 31 March 2020
6th Apr 20203:49 pmRNSNEWSLETTER 06/04/2020
2nd Apr 202011:59 amRNSPortfolio Company Update: GALY CO.
2nd Apr 20207:00 amRNSPortfolio Company Update: GALY CO
1st Apr 20207:00 amRNSFurther investment in Rebellyous Foods
31st Mar 202010:56 amRNSSubscription of US$2,999,996 in Tropic Biosciences
13th Mar 20207:00 amRNSPortfolio Company Update: Foods United
10th Mar 20207:00 amRNSInvestment of US$ 500,000 in GALY CO.
27th Feb 20207:00 amRNSPortfolio Company BlueNalu Announces Financing
13th Feb 20207:00 amRNSAdditional Investment of US$1 Million in VitroLabs
12th Feb 20207:00 amRNSInvestment of US$3million in Foods United
4th Feb 20201:04 pmRNSResult of AGM
31st Jan 20204:42 pmRNSHolding(s) in Company
28th Jan 20203:58 pmRNSHolding(s) in Company
24th Jan 20201:00 pmRNSFurther Equity Fundraise of £5.5 million
16th Jan 20202:05 pmRNSSecond Price Monitoring Extn
16th Jan 20202:00 pmRNSPrice Monitoring Extension
16th Jan 20207:00 amRNSHalf-year Report
27th Dec 201912:30 pmRNSIssue of Equity
20th Dec 20197:00 amRNSInvestment in Meatable BV
19th Dec 20197:00 amRNSAdditional Participation in BlueNalu Fundraise
18th Dec 20197:00 amRNSInvestment in LegenDairy Foods GmbH
16th Dec 20194:02 pmRNSHolding(s) in Company
16th Dec 20193:33 pmRNSHolding(s) in Company
12th Dec 20196:01 pmRNSHolding(s) in Company
11th Dec 201912:00 pmRNSInvestment in Oritain Global Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.